Worldwide Gene Therapy Industry to 2028 - Increasing Adoption of Gene Therapy for Oncological Disorders Will Provide Growth Opportunities
September 15, 2022 07:23 ET
|
Research and Markets
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's...
Avid Bioservices to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
September 07, 2022 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
September 06, 2022 16:05 ET
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business
September 01, 2022 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
August 30, 2022 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
The Worldwide Viral Vectors and Plasmid DNA Manufacturing Industry is Expected to Reach $2.7 Billion by 2027
August 25, 2022 04:58 ET
|
Research and Markets
Dublin, Aug. 25, 2022 (GLOBE NEWSWIRE) -- The "Global Viral Vectors and Plasmid DNA Manufacturing Market (2022-2027) by Product Type, Application, Geography, Competitive Analysis and the Impact of...
Global Gene Therapy Market Report 2022: Amid the COVID-19 Crisis, the Market is Projected to Reach a Revised Size of $2.7 Billion by 2026
August 19, 2022 05:08 ET
|
Research and Markets
Dublin, Aug. 19, 2022 (GLOBE NEWSWIRE) -- The "Gene Therapy - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Gene Therapy Market to...
Global Gene Therapy Market 2022-2027: Rising Funding for Gene Therapy Research Boosting Sector
August 12, 2022 04:43 ET
|
Research and Markets
Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Gene Therapy Market by Vectors (Non-viral(Oligonucleotides), Viral(Retroviral, Adeno-associated)), Indication (Cancer, Neurological,...
Global Viral Vector & Plasmid DNA Manufacturing Market Report to 2027 - Featuring ABL, Biovian and GE Healthcare Among Others
July 28, 2022 06:13 ET
|
Research and Markets
Dublin, July 28, 2022 (GLOBE NEWSWIRE) -- The "Viral Vector & Plasmid DNA Manufacturing Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's...
Avid Bioservices Reports Financial Results for Fourth Quarter and Full Fiscal Year Ended April 30, 2022 and Recent Developments
June 29, 2022 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Fourth Quarter and Full Fiscal Year Revenue of $31 Million and $120 Million, Respectively -- -- Signed $44 Million in Net New Business Orders and Ended the Quarter with a Record High...